Adult Neurology Disorders and Low THC CBD in Texas

Adult Neurology Disorders Qualifying for THC Cannabis - Altzheimer Parkinsons CTE

The rule is published and effective 5 Dec 2019 

https://www.sos.texas.gov/texreg/archive/November292019/Adopted%20Rules/25.HEALTH%20SERVICES.html

§1.61. Incurable Neurodegenerative Diseases.

(a) An incurable neurodegenerative disease is a condition, injury, or illness:

          (1) that occurs when nerve cells in the brain or peripheral nervous system lose function over time; and

          (2) for which there is no known cure.

(b) A qualifying physician under Texas Occupations Code, Chapter 169, may prescribe low-THC cannabis to a patient with a documented diagnosis of one or more of the following incurable neurodegenerative diseases:

          (1) Incurable Neurodegenerative Diseases with Adult Onset:

                   (A) Motor Neuron Disease:

                             (i) Amyotrophic lateral sclerosis;

                             (ii) Spinal-bulbar muscular atrophy; and

                             (iii)  Spinal Muscular Atrophy.

                   (B) Muscular Dystrophies:

                             (i) Duchenne Muscular Dystrophy;

                             (ii) Central Core; and

                             (iii) Facioscapulohumeral Muscular Dystrophy.

                   (C) Freidrich’s Ataxia.

                   (D) Vascular dementia.

                   (E) Charcot Marie Tooth and related hereditary neuropathies.

                   (F) Spinocerebellar ataxia.

                   (G) Familial Spastic Paraplegia.

                   (H) Progressive dystonias DYT genes 1 through 20.

                   (I) Progressive Choreas: Huntington’s Disease.

                   (J) Amyloidoses:

                             (i) Alzheimer’s Disease;

                             (ii) Prion Diseases:

                                      (I) Creutzfeldt-Jakob Disease;

                                      (II) Gerstmann-Strausller-Scheinker Disease;

                                      (III) Familial or Sporadic Fatal Insomnia; and

                                      (IV) Kuru.

                   (K) Tauopathies.

                             (i) Chronic Traumatic Encephalopathy:

                             (ii) Pick Disease;

                             (iii) Globular Glial Tauopathy;

                             (iv) Corticobasal Degeneration;

                             (v) Progressive Supranuclear Palsy;

                             (vi) Argyrophilic Grain Disease;

                             (vii) Neurofibrillary Tangle dementia, also known as Primary Age-related Tauopathy; and

                             (viii) Frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in MAPT gene.

                   (L) Synucleinopathies:

                             (i) Lewy Body Disorders:

                                      (I) Dementia with Lewy Bodies; and

                                      (II) Parkinson’s Disease; and

                             (ii) Multiple System Atrophy.

                   (M) Transactive response DNA-binding protein-43 (TDP-43) Proteinopathies:

                             (i) Frontotemporal Lobar Degeneration;

                             (ii) Primary Lateral Sclerosis; and

                             (iii) Progressive Muscular Atrophy.